In an increasingly hot biotech market, protecting IP is key – TechCrunch
More posts by this contributor 2021 should be a banner year for biotech startups that make smart choices early Kevin O’Connor Contributor Kevin A. O’Connor, Ph.D., is a partner in the Intellectual Property practice group at Neal Gerber Eisenberg. After a record year for biotech investment in 2020 — during which the industry saw $28.5…